Shares of Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report) shot up 16.3% during trading on Thursday . The stock traded as high as $5.45 and last traded at $2.50. 470 shares traded hands during trading, a decline of 68% from the average session volume of 1,459 shares. The stock had previously closed at $2.15.
Silence Therapeutics Stock Up 16.3 %
The stock has a 50 day moving average price of $5.62 and a two-hundred day moving average price of $6.44.
Silence Therapeutics Company Profile
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
Recommended Stories
- Five stocks we like better than Silence Therapeutics
- Stock Sentiment Analysis: How it Works
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- NYSE Stocks Give Investors a Variety of Quality Options
- 3 Penny Stocks Ready to Break Out in 2025
- Compound Interest and Why It Matters When Investing
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
